中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

14 records (took 0.014 seconds)

    FLOW CYTOMETER APPARATUS FOR THREE DIMENSIONAL DIFFRACTION IMAGING AND RELATED METHODS
    4.
    发明申请
    FLOW CYTOMETER APPARATUS FOR THREE DIMENSIONAL DIFFRACTION IMAGING AND RELATED METHODS 审中-公开
    用于三维差分成像的流式细胞仪装置及相关方法

    公开(公告)号：WO2009151610A3

    公开(公告)日：2010-03-11

    申请号：PCT/US2009003508

    申请日：2009-06-11

    Applicant: UNIV EAST CAROLINA ,  HU XIN-HUA ,  JACOBS KENNETH M ,  LU JUN O

    Inventor： HU XIN-HUA ,  JACOBS KENNETH M ,  LU JUN O

    IPC: G01N15/14 ,  G01N33/487

    CPC classification number: G01N15/1475 ,  G01N15/0211 ,  G01N15/147 ,  G01N2015/0222 ,  G01N2015/025 ,  G01N2015/1497

    Abstract: A flow cytometer assembly includes a fluid controller configured to form a hydrodynamically focused flow stream including an outer sheath fluid and an inner core fluid. A coherent light source is configured to illuminate a particle in the inner core fluid. A detector is configured to detect a spatially coherent distribution of elastically scattered light from the particle excited by the coherent light source. An analyzing module configured to extract a three-dimensional morphology parameter of the particle from a spatially coherent distribution of the elastically scattered light.

    Abstract translation: 流式细胞仪组件包括流体控制器，该流体控制器被配置为形成包括外护套流体和内芯流体的流体动力学聚焦的流动流。 相干光源被配置为照亮内芯流体中的颗粒。 检测器被配置为检测来自由相干光源激发的粒子的弹性散射光的空间相干分布。 分析模块，被配置为从所述弹性散射光的空间相干分布中提取所述粒子的三维形态参数。

    INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR
    5.
    发明申请
    INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR 审中-公开
    白细胞介素-17F抗体及其他IL-17F信号拮抗剂及其用途

    公开(公告)号：WO2006088833A2

    公开(公告)日：2006-08-24

    申请号：PCT/US2006/005111

    申请日：2006-02-14

    Applicant: WYETH ,  CARRENO, Beatriz, M. ,  COLLINS, Mary ,  WRIGHT, Jill, F. ,  WOLFMAN, Neil, M. ,  ARAI, Maya ,  JACOBS, Kenneth ,  LU, Zhijian ,  GUO, Yongjing ,  QIU, Yongchang

    Inventor： CARRENO, Beatriz, M. ,  COLLINS, Mary ,  WRIGHT, Jill, F. ,  WOLFMAN, Neil, M. ,  ARAI, Maya ,  JACOBS, Kenneth ,  LU, Zhijian ,  GUO, Yongjing ,  QIU, Yongchang

    IPC: C07K16/24 ,  C07K16/28 ,  C07K14/54 ,  C07K14/715 ,  C12N15/11 ,  G01N33/68 ,  A61K39/39 ,  A61K39/395 ,  A61P37/00 ,  A61P29/00 ,  A61K38/20

    CPC classification number: C07K16/244 ,  A61K38/00 ,  A61K2039/505 ,  A61K2039/55527 ,  C07K14/54 ,  C07K14/7155 ,  C07K16/2866 ,  C07K2317/76 ,  C07K2319/30 ,  C12N15/1138 ,  G01N33/6869

    Abstract: The present invention provides isolated and purified polynucleotides and polypeptides related to the IL-17F signaling pathway. The invention also provides antibodies to IL-17F homodimers and IL-17A/IL-17F heterodimers, and methods of isolating and purifying members of the IL-17 family, including IL-17A/IL-17F heterodimers, from a natural source. The present invention also is directed to novel methods for diagnosing, prognosing, monitoring the progress of, and treating and/or preventing disorders related to IL-17F signaling, i.e., IL-17F-associated disorders, including, but not limited to, inflammatory disorders, such as autoimmune diseases (e.g., arthritis (including rheumatoid arthritis), psoriasis, systemic lupus erythematosus, and multiple sclerosis), respiratory diseases (e.g., COPD, cystic fibrosis, asthma, allergy), transplant rejection (including solid organ transplant rejection), and inflammatory bowel diseases or disorders (IBDs, e.g., ulcerative colitis, Crohn's disease). The present invention is further directed to novel therapeutics and therapeutic targets, and to methods of screening and assessing test compounds for the intervention (treatment) and prevention of disorders related to IL-17F signaling.

    Abstract translation: 本发明提供与IL-17F信号通路相关的分离和纯化的多核苷酸和多肽。 本发明还提供了对IL-17F同源二聚体和IL-17A / IL-17F异二聚体的抗体，以及从天然来源分离和纯化IL-17家族成员（包括IL-17A / IL-17F异源二聚体）的方法。 本发明还涉及用于诊断，预后，监测与IL-17F信号传导相关的疾病的进展和/或预防的新方法，即IL-17F相关疾病，包括但不限于炎性 诸如自身免疫性疾病（例如关节炎（包括类风湿性关节炎），牛皮癣，系统性红斑狼疮和多发性硬化症），呼吸系统疾病（例如COPD，囊性纤维化，哮喘，过敏），移植排斥（包括实体器官移植排斥 ）和炎症性肠病或疾病（IBD，例如溃疡性结肠炎，克罗恩病）。 本发明还涉及新的治疗和治疗靶标，以及筛选和评估用于干预（治疗）的试验化合物和预防与IL-17F信号传导相关的紊乱的方法。

    DECORATIVE LAMINATED MIRROR DOOR
    6.
    发明申请
    DECORATIVE LAMINATED MIRROR DOOR 审中-公开
    装饰层压门镜

    公开(公告)号：WO2005103431A1

    公开(公告)日：2005-11-03

    申请号：PCT/IB2005/001510

    申请日：2005-04-18

    Applicant: JACOBS, Kenneth

    Inventor： JACOBS, Kenneth

    IPC: E06B3/70

    CPC classification number: E06B3/7001 ,  B44C5/0407

    Abstract: An inexpensive, light-weight decorative door panel includes a glass panel (90) that substantially defines a height and width of the door panel (30,40). One or more thin decorative sheets (100) are laminated to the front surface (90a) of the glass panel (90). Trim pieces (110,120) are applied to the peripheral intersections between the sheets (100) and the front surface (90a) such that the decorative door panel (30,40) appears to comprise a combination of discrete door panels. A plurality of these decorative door panels (30) are movably or fixedly mounted to a mounting assembly (20) to create a room partition.

    Abstract translation: 一种价格便宜，重量轻的装饰门板包括基本上限定门板（30,40）的高度和宽度的玻璃面板（90）。 一个或多个薄的装饰片（100）被层压到玻璃面板（90）的前表面（90a）上。 修剪件（110,120）被施加到片材（100）和前表面（90a）之间的周边交叉处，使得装饰性门板（30,40）看起来包括离散门板的组合。 多个这些装饰门板（30）可移动地或固定地安装到安装组件（20）上以形成房间隔板。

    INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR
    8.
    发明申请
    INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR 审中-公开
    白细胞介素-17F抗体和其他IL-17F信号拮抗剂及其用途

    公开(公告)号：WO2006088833A3

    公开(公告)日：2006-11-23

    申请号：PCT/US2006005111

    申请日：2006-02-14

    Applicant: WYETH CORP ,  CARRENO BEATRIZ M ,  COLLINS MARY ,  WRIGHT JILL F ,  WOLFMAN NEIL M ,  ARAI MAYA ,  JACOBS KENNETH ,  LU ZHIJIAN ,  GUO YONGJING ,  QIU YONGCHANG

    Inventor： CARRENO BEATRIZ M ,  COLLINS MARY ,  WRIGHT JILL F ,  WOLFMAN NEIL M ,  ARAI MAYA ,  JACOBS KENNETH ,  LU ZHIJIAN ,  GUO YONGJING ,  QIU YONGCHANG

    IPC: C07K16/24 ,  A61K38/20 ,  A61K39/39 ,  A61K39/395 ,  A61P29/00 ,  A61P37/00 ,  C07K14/54 ,  C07K14/715 ,  C07K16/28 ,  C12N15/113 ,  G01N33/68

    CPC classification number: C07K16/244 ,  A61K38/00 ,  A61K2039/505 ,  A61K2039/55527 ,  C07K14/54 ,  C07K14/7155 ,  C07K16/2866 ,  C07K2317/76 ,  C07K2319/30 ,  C12N15/1138 ,  G01N33/6869

    Abstract: The present invention provides isolated and purified polynucleotides and polypeptides related to the IL-17F signaling pathway. The invention also provides antibodies to IL-17F homodimers and IL-17A/IL-17F heterodimers, and methods of isolating and purifying members of the IL-17 family, including IL-17A/IL-17F heterodimers, from a natural source. The present invention also is directed to novel methods for diagnosing, prognosing, monitoring the progress of, and treating and/or preventing disorders related to IL-17F signaling, i.e., IL-17F-associated disorders, including, but not limited to, inflammatory disorders, such as autoimmune diseases (e.g., arthritis (including rheumatoid arthritis), psoriasis, systemic lupus erythematosus, and multiple sclerosis), respiratory diseases (e.g., COPD, cystic fibrosis, asthma, allergy), transplant rejection (including solid organ transplant rejection), and inflammatory bowel diseases or disorders (IBDs, e.g., ulcerative colitis, Crohn's disease). The present invention is further directed to novel therapeutics and therapeutic targets, and to methods of screening and assessing test compounds for the intervention (treatment) and prevention of disorders related to IL-17F signaling.

    Abstract translation: 本发明提供了与IL-17F信号传导途径相关的分离和纯化的多核苷酸和多肽。 本发明还提供针对IL-17F同二聚体和IL-17A / IL-17F异二聚体的抗体，以及从天然来源分离和纯化IL-17家族成员（包括IL-17A / IL-17F异二聚体）的方法。 本发明还涉及用于诊断，预测，监测IL-17F信号传导即IL-17F相关病症（包括但不限于炎症）的进展和治疗和/或预防与IL-17F信号传导相关的病症的新方法 （例如，关节炎（包括类风湿性关节炎），牛皮癣，系统性红斑狼疮和多发性硬化症），呼吸系统疾病（例如COPD，囊性纤维化，哮喘，变态反应），移植排斥（包括实体器官移植排斥 ）和炎性肠病或病症（IBD，例如溃疡性结肠炎，克罗恩氏病）。 本发明还涉及新的治疗剂和治疗靶，以及筛选和评估测试化合物用于干预（治疗）和预防与IL-17F信号传导相关的病症的方法。

Patent Agency Ranking